Literature DB >> 7075290

Adverse response to nifedipine in unstable angina pectoris.

M Yokoyama, T Koizumi, K Fujitani, T Mizutani, H Fukuzaki.   

Abstract

A patient had accelerated attacks of chest pain associated with transient ST elevation or depression in the anterior leads. Coronary angiogram revealed severe multi-vessel disease. Anginal attacks with conspicuous ST depression were induced repeatedly by both oral and sublingual administration of nifedipine. Among various vasodilator drugs tested on this patient, dipyridamole and hydralazine induced anginal attacks. These observations suggest that anginal attacks induced by administration of nifedipine may be related to the augmentation of myocardial oxygen consumption due to increases in cardiac output and heart rate, the coronary steal phenomenon, or an increase in venous return accompanied by the subendocardial underperfusion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075290     DOI: 10.1378/chest.81.5.646

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.

Authors:  M Kyriakidis; G Vyssoulis; P Sfikakis; C Kyriakidis; C Pitsavos; K Valsamis; V Nomikos; P Toutouzas
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?

Authors:  D G Caralis; Z Kyriakides
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 4.  Nonresponsiveness to antianginal therapy--a frequent problem?

Authors:  W Schulz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 5.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.